Z-SYMBOLS

More on Vaxart potential gains and risks–including my thoughts on when to re-enter

More on Vaxart potential gains and risks–including my thoughts on when to re-enter

I thought there was a possibility that Vaxart (VXRT) would recover from yesterday’s 60% drop on data from the initial Phase 1 trials of its coronavirus-vaccine-in-a-pill candidate. Especially because the initial reaction over-emphasized, in my opinion, the negatives in that data. But I suspected that yesterday’s downward trend would continue for at least another day and therefore chose to sell Vaxart shares out of my Volatility Portfolio.

FCX hold: Mixed signals still add up to plus

FCX hold: Mixed signals still add up to plus

Back on January 26 copper miner Freeport McMoRan (FCX) dropped sharply–down 6.5%–when the company lowered guidance for production in 2021. For 2021 Freeport McMoRan expects sales of 3.8 billion pounds of copper and 1.3 million ounces of gold. In October the company guided analysts to production of 3.85 billion pounds of copper and 1.4 million ounces of gold. (Freeport-McMoRan did raised its 2022 target for copper sales to 4.3 billion pounds from 4.2 billion.) But the company did report fourth quarter earnings of 39 cents a share, matching Wall Street projections. In the fourth quarter of 2019, the company earned 2 cents a share. But…

NTCO Pick #7 for my new Millennial Portfolio (for investors with more time than money)

It’s hard being a long-term contrarian investor in a short term market dominated by momentum trading. But I think the rewards from that discipline will be substantial–if an investor has a long enough time horizon to wait out short-term negative trends.
Today, I’m adding Natura & Company Holding (NTCO) to my Millennial Portfolio.

More on Vaxart potential gains and risks–including my thoughts on when to re-enter

Vaxart is looking like a “short-squeeze rocket”–is it?

Ok, I don’t want to see “the next GameStop under every rock.” But Vaxart (VXRT) deserves a look or two. (The stock is a member of my Volatility Portfolio where it’s up 5.27 as of the close on February 1 since I added it to the portfolio on July 22, 2020. I also own shares in my personal portfolio.) Here’s what I see with the shares of this company that is in clinical trials of a vaccine for the coronavirus. Vaxart’s vaccine is a pill and it’s the only vaccine pill under development. Shares of Vaxart are up (as of the February 1 close) 54.93% in the last week and 172.68% in the last month. They’ve added 216.46% in the last 3 months and are up 172.68% for 2021 to date as of the close on February 1. The shares moved up another 29.97% today to $15.57 a share.

Nektar should be climbing but this fast?

Nektar should be climbing but this fast?

Nektar (NKTR) is another one of those stocks that looks to be moving up more strongly right now than the relatively sparse news would explain. Shares of this biotech are up 18.96% in the last week and 24.37% for the last 3 months. I can see a stream of positive news that should be leading the stock gradually higher, but nothing that is especially “current.”

Accepting what we don’t know (what no one knows) about prices in this market

Accepting what we don’t know (what no one knows) about prices in this market

I looked at my Jubak Picks Portfolio with more than a tinge of seller’s remorse this morning. I sold shares of First Majestic Silver (AG) out of that portfolio on Friday, January 29, after the stock rose 21.38% on Thursday. That gave me a gain of 45.52% since I began this position on July 6, 2019.I argued in justification for this sell that the attempt by individual investors on Reddit’s WallStreetBets forum to force a short squeeze in silver, as they had in GameStop (GME), were likely to fail because there was such a big stockpile of physical silver ready to enter the market. So I took my profit. Only to have the stock climb an other 21.3% today, February 1, as of 2:30 p.m. New York time as individual investors did indeed drive up the price of silver futures. The Shares Silver Trust (SLV) was up 6.40% as of 2:30 New York time today as the intraday price of silver limbed to the highest level since 2013. And then I thought about that seller’s remorse.

Selling First Majestic Silver on Friday on Reddit rally

Selling First Majestic Silver on Friday on Reddit rally

Shares of First Majestic Silver (AG) climbed 21.38% yesterday, January 28, as silver futures climbed on a post on Reddit suggesting profit from a short squeeze on silver. “Any short squeeze in silver paper shorts would be EPIC,” a post on Reddit’s WallStreetBets forum said. “Why not squeeze SLV to real physical price,” the poster said referring to the iShares Silver Trust ETF (SLV). That ETF closed up 5.55% on Thursday. Now I understand the attraction of anything that can be touted as a potential for a short squeeze like that which has driven the shares of GameStop (GME) up 928% for 2021 as of the close on January 28, and 1538% in the last three months. But silver the commodity is actually very different from a stock and a short-squeeze looks very difficult to execute in silver.

Market sees fourth quarter GDP slowdown as good news

Market sees fourth quarter GDP slowdown as good news

U.S. GDP growth slowed in the fourth quarter, gaining just 1% from the third quarter. For the full year the U.S. economy contracted by 3.5%. That makes 2020 the first time that the economy has contracted for a full year since 2009 and the Great Recession. At the bottom of that recession that economy contracted by 2.5%. 2020 is also the worst year for economic growth since 1946 when the economy shrank by 11.6% as the country demobilized after World War II. Consumer spending slowed in all 15 categories tracked by the Bureau of Economic Analysis. The sectors that had powered the recovery in the third quarter–restaurants and hotels, for instance–reversed. The growth in spending on cars and health car also slowed from the acceleration in the third quarter. So why is this good news as far as the stock market is concerned?

Microsoft blows away analyst earnings projections after close today; Apple and Facebook report tomorrow

Microsoft blows away analyst earnings projections after close today; Apple and Facebook report tomorrow

Microsoft reported its earnings for the company’s fiscal second quarter 2021 earnings today, Tuesday, January 26, after the close. Revenue of $43.1 billion easily beat Wall Street projections of $40.2 billion. Earnings per share of $2.03 crushed expectations for $1.64 a share. Microsoft’s shares were up 1.22% in the regular session and then gained another 4.30% in after-hours trading.

Nidec tacks on 7.69% gain today on updated annual forecast and new buyback plan

Nidec tacks on 7.69% gain today on updated annual forecast and new buyback plan

Nidec (NJDCY) shares gained another 7.69% today, after the maker of electric motors for hard drives, robots, and electric vehicles, raised its annual outlook for the fiscal year that ends on March 31. The new outlook forecasts operating income of 155 billion yen ($1.5 billion) versus the older forecast of 140 billion yen. The company authorized share buybacks of up to 50 billion yen, or about 0.7% of the company’s stock.